Research News and Research

RSS

Waxman Foundation honors molecular biologist Alan Ashworth with the David T. Workman Memorial Award

Molecular biologist Alan Ashworth, Ph.D., FRS, the director of the Breakthrough Breast Cancer Research Centre at the Institute of Cancer Research in London will receive the David T. Workman Memorial Award on May 17. The two-year grant of $50,000 from the Samuel Waxman Cancer Research Foundation will support Dr. Ashworth's work with PARP inhibitors in BRCA-mutated cancers.

23 Apr 2010

COSMOS project launched to investigate link between use of mobile phones and health problems

A new decades-long study launches today to investigate whether there is a link between the use of mobile phones and long-term health problems such as cancer.

23 Apr 2010

CSL Biotherapies comments on influenza vaccine paediatric adverse events

CSL Biotherapies is aware of reports of a number of adverse events following influenza vaccination of children. CSL is one of several suppliers of influenza vaccine in Australia.

23 Apr 2010

Investigators raid N.Y. Senate official's office, seeking evidence in Medicare, Medicaid fraud lawsuit

Federal and state investigators raided the Bronx offices of the Soundview HealthCare Network early Wednesday, seeking records as part of a joint investigation into the business and political activities of the Senate majority leader, Pedro Espada, Jr. More than a dozen agents from the Federal Bureau of Investigation and the Internal Revenue Service, joined by investigators from the office of Attorney General Andrew M. Cuomo, arrived at Soundview's offices on White Plains Road shortly before 7 a.m., when the first employees arrived to open the doors for the day.

23 Apr 2010

isrp awarded $16M grant to study health effects of environmental pollutants

The National Institute of Environmental Health Sciences has awarded the University of Iowa Superfund Research Program (isrp) a five-year, $16 million grant to study the health effects of environmental pollutants, especially polychlorinated biphenyls (PCBs) found in water, former industrial sites and the atmosphere.

23 Apr 2010

TUM scientists collaborate with Fujitsu Laboratories of Japan to commercialize biosensor chip

In the battle against cancer and other diseases, precise analysis of specific proteins can point the way toward targeted treatments. Scientists at theTechnische Universitaet Muenchen, together with Fujitsu Laboratories of Japan, have developed a novel biosensor chip that not only recognizes proteins that are characteristic for specific diseases, but also can show if these proteins are changed through the influence of disease or drugs.

23 Apr 2010

BUSM professor receives Individual Biomedical Research Award

Richard Goldstein, PhD, a professor of pediatrics, division of pediatric infectious diseases, at Boston University School of Medicine, has been awarded an Individual Biomedical Research Award by The Hartwell Foundation and will receive $300,000 over three years as a Hartwell Investigator for his project titled, "A Vaccine Against Streptococcus Pneumoniae Based on Bacterial Surface Proteins Phylogenically Certified as Highly Conserved."

23 Apr 2010

House passes measure to boost veterans medical benefits

The Los Angeles Times: "The House voted 419 to 0 on Wednesday to approve new benefits and financial support for the primary live-in caregivers of seriously wounded veterans who served in the wars in Iraq and Afghanistan. The measure, which would cost about $1.7 billion over five years, is part of comprehensive legislation that would permit the Department of Veterans Affairs to expand its assistance to family members of veterans generally." The bill calls for rates on a par with "commercial rates for home caregivers" (Tan, 4/21).

23 Apr 2010

Despite federal help, states struggle to move people out of nursing homes

Kaiser Health News staff writer Phil Galewitz, working in collaboration with USA Today, writes about the Money Follows The Person program: "Richard Hasselbach and Deborah Kadlec met in a nursing home and dreamed of a life together outside its walls.

23 Apr 2010

Gelesis presents Attiva data at AACE 19th Annual Meeting & Clinical Congress

Boston-based medical technology firm Gelesis, Inc. unveiled its capsulated device Attiva™, and presented data showing that Attiva™ significantly increased the post-meal feeling of satiety and reduced hunger between meals in obese patients. This data was presented today at the American Association of Clinical Endocrinologists (AACE) 19th Annual Meeting & Clinical Congress.

23 Apr 2010

Sleep improves memory

The next time you want to remember what you were taught, take a nap and dream about it. You may just remember it better. That is what scientists at the Center for Sleep and Cognition at Beth Israel Deaconess Medical Center in Boston, Massachusetts had to say after a new study. Robert Stickgold the lead author confirmed that a nap would improve the chances of your remembering stuff if you dream it.

23 Apr 2010

Biological activity of Curis' CUDC-101 HDAC, EGFR and HER2 inhibitor published in Cancer Research

Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that a research paper describing the biological activity of its HDAC, EGFR and HER2 inhibitor, CUDC-101, was published online in the journal Cancer Research and also will be published in an upcoming print version of the journal.

23 Apr 2010

Cisco uses telemedicine in Southern Calif. and Southwest to lower costs

Cisco is using its HealthPresence telemedicine system in new programs in Southern California and the Southwest to "compete with other major tech companies, including Intel, IBM and General Electric, in the growing market for health-care products and services," The San Jose Mercury News/The (Raleigh, N.C.) News & Observer reports.

23 Apr 2010

IAVI, Lentigen to design preventive AIDS vaccine

The International AIDS Vaccine Initiative and Lentigen today announced a collaboration to design a preventive AIDS vaccine based on Lentigen's technology. The candidate AIDS vaccine will be devised to safely mimic biological aspects of HIV infection and tested first in pre-clinical studies as part of an initial 18-month agreement.

23 Apr 2010

Physical exercise and computer use may help protect against mild cognitive impairment: Mayo Clinic

A new Mayo Clinic study found that physical exercise and computer use may help protect against mild cognitive impairment, a disorder of the brain that affects nerve cells involved in thinking abilities.

23 Apr 2010

Celator Pharmaceuticals presents data on CPX-351 Liposome Injection and HDPN formulation

Celator Pharmaceuticals today announced data from animal studies demonstrating the superior bone marrow uptake of CPX-351 (Cytarabine:Daunorubicin) Liposome Injection, its lead clinical-stage program, as well as the enhanced circulation kinetics and efficacy of its preclinical hydrophobic docetaxel prodrug nanoparticle (HDPN) formulation were presented at the 101st Annual Meeting of the American Association for Cancer Research in Washington, DC (Abstracts 3698 and 5534).

23 Apr 2010

Miss. lawmakers want voters to have say on health coverage mandate

Two Republican lawmakers in Mississippi want voters there to have the final say on whether purchasing health insurance should be required as mandated by the new federal health reform law. State Reps. Alex Monsour and Steven Palazzo are proposing a ballot initiative to ask voters the question.

23 Apr 2010

Study: California's nursing-ratio law saves patients' lives

News outlets report on a study suggesting that California's mandatory nursing-ratio law saves patient lives.

23 Apr 2010

NeoStem signs Collaborative Research Agreement with ImmuneRegen BioSciences

NeoStem, Inc., an international biopharmaceutical company with operations in the U.S. and China and ImmuneRegen BioSciences, Inc., a wholly owned subsidiary of IR BioSciences Holdings, Inc., announced today that they have entered into a Collaborative Research Agreement, focused on the development of an advanced, adult human stem cell product.

23 Apr 2010

OSI Pharmaceuticals' first-quarter 2010 total revenues increase 14% to $107M

OSI Pharmaceuticals, Inc. announced today its financial results for the first quarter ended March 31, 2010. The Company reported total revenues from continuing operations of $107 million for the first quarter of 2010, a 14% increase over revenues of $94 million for the first quarter of 2009.

23 Apr 2010